Diagnosis of Periodontal Disease Using Genetic Marker in Saliva
NCT ID: NCT02069574
Last Updated: 2014-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
18 participants
INTERVENTIONAL
2014-03-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
miRNAs in Periodontal Disease
NCT05046678
Salivary Markers in Periodontal Disorders
NCT06576856
Effect of Periodontal Treatment on Salivary Biomarkers
NCT02159781
Role of miRNAs in CVD and Periodontitis
NCT05383794
Systemic Markers of Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical Periodontal Therapy
NCT04312542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
severe periodontitis group
non-surgical periodontal therapy
non-surgical periodontal therapy
Moderate periodontitis group
non-surgical periodontal therapy
non-surgical periodontal therapy
healthy control
No treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
non-surgical periodontal therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with chronic severe periodontitis
* Primary treatment of periodontal scaling, subgingival curettage is required, and the general progress of the protocol agreed with the basic periodontal therapy patients.
* subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing
A. Moderate Periodontal Disease
* Patients with chronic moderate periodontitis
* Primary treatment of periodontal scaling, subgingival curettage is required, and the general progress of the protocol agreed with the basic periodontal therapy patients.
* subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing
C. Healthy Control
* Healthy periodontal patients ( more than 20 permanent teeth are present , in all parts of deep periodontal pockets measuring 4mm or less, and height is 2mm or less clinical attachment person)
* subjects agreed collecting saliva and gingival crevicular fluid and physicochemical tests and genetic testing
Exclusion Criteria
* recently taken antibiotics within 3 months if you need a prescription antibiotic prophylaxis
* taking the drug can affect periodontal status for a long period of time
* pregnant or breastfeeding
* In case of oral inflammatory mucosal disease (Lichen planus, etc.)
* A history of alcoholism or drug abuse if
* other special systemic disease (high blood pressure)
* ages under 18
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Su-Hwan Kim
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Su-Hwan Kim, PhD.
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASAN Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-0940
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.